Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats

Journal of Neuroscience Research

Volumn 88, Issue 8, 2010, Pages 1738-1750

  Sribnick, Eric A ^a   Samantaray, Supriti ^a   Das, Arabinda ^a   Smith, Joshua ^a   Matzelle, D Denise ^a   Ray, Swapan K ^b   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal damage; Cell death; Chronic spinal cord injury; Estrogen; Locomotor function

Indexed keywords

CALPAIN; CYCLOOXYGENASE 2; ESTROGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELIN; NEUROFILAMENT PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DENSITY; CHEMICAL ANALYSIS; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME INHIBITION; ESTROGEN THERAPY; GENE TRANSLOCATION; GLIA CELL; LOCOMOTION; MACROPHAGE; MALE; MYELITIS; NERVE CELL; NERVE CELL NECROSIS; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; SPINAL CORD INJURY; SPINAL CORD LESION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; AXONS; BCL-2-ASSOCIATED X PROTEIN; CALPAIN; CASPASE 3; CHRONIC DISEASE; COLORIMETRY; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ESTROGENS; FLAVOPROTEINS; I-KAPPA B PROTEINS; INDOLES; MACROPHAGES; MALE; MOTOR ACTIVITY; NERVE FIBERS, MYELINATED; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 77952357815     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22337     Document Type: Article

References (65)

1. 2+ exchanger. J Neurosci 16:545-552.
2. Agrawal SK, Nashmi R, Fehlings MG. 2000. Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience 99:179-188. (Pubitemid 30495562)
3. Aronica SM, Fanti P, Kaminskaya K, Gibbs K, Raiber L, Nazareth M, Bucelli R, Mineo M, Grzybek K, Kumin M, Poppenberg K, Schwach C, Janis K. 2004. Estrogen disrupts chemokine-mediated chemokine release from mammary cells: implications for the interplay between estrogen and IP-10 in the regulation of mammary tumor formation. Breast Cancer Res Treat 84:235-245. (Pubitemid 38445373)
4. Banik NL, Hogan EL, Jenkins MG, McDonald JK, McAlhaney WW, Sostek MB. 1983. Purification of a calcium-activated neutral proteinase from bovine brain. Neurochem Res 8:1389-1405. (Pubitemid 14200496)
5. Bartus RT, Hayward NJ, Elliott PJ, Sawyer SD, Baker KL, Dean RL, Akiyama A, Straub JA, Harbeson SL, Li Z, et al. 1994. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of post-occlusion intra-arterial administration. Stroke 25:2265-2270.
6. Barut S, Canbolat A, Bilge T, Aydin Y, Cokneseli B, Kaya U. 1993. Lipid peroxidation in experimental spinal cord injury: time-level relationship. Neurosurg Rev 16:53-59. (Pubitemid 23132173)
7. Basso DM, Beattie MS, Bresnahan JC. 1995. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21.
8. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device vs. transection. Exp Neurol 139:244-256.
9. Bayir H, Marion DW, Puccio AM, Wisniewski SR, Janesko KL, Clark RS, Kochanek PM. 2004. Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 21:1-8. (Pubitemid 38141797)
10. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. 1998. Traumatic spinal cord injury induces nuclear factor-κB activation. J Neurosci 18:3251-3260. (Pubitemid 28186018)
11. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, Mallard C, Hagberg H. 2001. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 276:10191-10198.
12. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings MG, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. 1998. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg 89:699-706. (Pubitemid 28485526)
13. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. 1998. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151:77-88. (Pubitemid 28223857)
14. Das A, Sribnick EA, Wingrave JM, Del Re AM, Woodward JJ, Appel SH, Banik NL, Ray SK. 2005. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res 81:551-562. (Pubitemid 41297392)
15. Dhillon HS, Carman HM, Prasad RM. 1999. Regional activities of phospholipase C after experimental brain injury in the rat. Neurochem Res 24:751-755. (Pubitemid 29270458)
16. Dimayuga FO, Reed JL, Carnero GA, Wang C, Dimayuga ER, Dimayuga VM, Perger A, Wilson ME, Keller JN, Bruce-Keller AJ. 2005. Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol 161:123-136. (Pubitemid 40340880)
17. Dodel RC, Du Y, Bales KR, Gao F, Paul SM. 1999. Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglial cultures following exposure to amyloid Aβ (1-40) and lipopolysaccharides. J Neurochem 73:1453-1460. (Pubitemid 29440145)
18. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. 1999. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 19:6385-6393. (Pubitemid 29347438)
19. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM. 2001. Estrogen receptor a, not b, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 98:1952-1957. (Pubitemid 32165604)
20. Gao MX, Li K, Dong J, Liege S, Jiang B, Neveu PJ. 2000. Strain-dependent association between lateralization and lipopolysaccharide-induced IL-1β and IL-6 production in mice. Neuroimmunomodulation 8:78-82.
21. Groswasser Z, Cohen M, Keren O. 1998. Female TBI patients recover better than males. Brain Inj 12:805-808. (Pubitemid 28425306)
22. Guyton MK, Wingrave JM, Yallapragada AV, Wilford GG, Sribnick EA, Matzelle DD, Tyor WR, Ray SK, Banik NL. 2005. Up-regulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res 81:53-61.
23. Hurlbert RJ. 2000. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 93(Suppl 1):1-7. (Pubitemid 30457375)
24. Jover T, Tanaka H, Calderone A, Oguro K, Bennett MV, Etgen AM, Zukin RS. 2002. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J Neurosci 22:2115-2124. (Pubitemid 35390362)
25. 2+ exchange in spinal cord white matter injury at physiological temperature. J Neurophysiol 84:1116-1119.
26. Linford NJ, Dorsa DM. 2002. 17b-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67:1029-1040.
27. Mills CD, Xu GY, Johnson KM, McAdoo DJ, Hulsebosch CE. 2000. AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury. Neuroreport 11:3067-3070.
28. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. 1999. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 163:374-379. (Pubitemid 29295863)
29. Moosmann B, Behl C. 1999. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 96:8867-8872. (Pubitemid 29374674)
30. Morales LB, Loo KK, Liu HB, Peterson C, Tiwari-Woodruff S, Voskuhl RR. 2006. Treatment with an estrogen receptor a ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26:6823-6833. (Pubitemid 44315243)
31. Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, Talanian RV, Yuen P, Gilbertsen RB, Wang KK. 1996. Non-erythroid α-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme- like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 319:683-690. (Pubitemid 26386177)
32. Nilsen J, Chen S, Brinton RD. 2002. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and Src/mitogen activated protein kinase pathway. Brain Res 930:216-234. (Pubitemid 34195646)
33. Pang Z, Bondada V, Sengoku T, Siman R, Geddes JW. 2003. Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology. J Neuropathol Exp Neurol 62:633-643. (Pubitemid 36682636)
34. Pant HC. 1988. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 256:665-668.
35. Perot PL Jr, Lee WA, Hsu CY, Hogan EL, Cox RD, Gross AJ. 1987. Therapeutic model for experimental spinal cord injury in the rat: I. Mortality and motor deficit. Cent Nerv Syst Trauma 4:149-159.
36. Popovich PG, Wei P, Stokes BT. 1997. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464. (Pubitemid 27016650)
37. Posmantur R, Kampfl A, Siman R, Liu J, Zhao X, Clifton GL, Hayes RL. 1997. A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77:875-888. (Pubitemid 27092142)
38. Ray SK, Banik NL. 2002. Calpain. In: Collins G, editor. The encyclopedia of molecular medicine. New York: John Wiley & Sons. p 435-440.
39. Ray SK, Hogan EL, Banik NL. 2003. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Rev 42:169-185. (Pubitemid 36549175)
40. Roof RL, Hall ED. 2000a. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J Neurotrauma 17:1155-1169.
41. Roof RL, Hall ED. 2000b. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 17:367-388.
42. Samantaray S, Knaryan VH, Guyton MK, Matzelle DD, Ray SK, Banik NL. 2007. The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience 146:741-755. (Pubitemid 46656209)
43. Samantaray S, Das A, Sribnick EA, Matzelle DD, Yu SP, Ray SK, Wei L, Banik NL. 2009. Neuroprotective efficacy of estrogen in acute and chronic spinal cord injury in rats. J Neurochem 108(Suppl S1):105 (PSM107-110).
44. Schaecher K, Goust JM, Banik NL. 2004. The effects of calpain inhibition on IjBa degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res 29:1443-1451. (Pubitemid 39011333)
45. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. 1999. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5:554-559. (Pubitemid 29220215)
46. Schumacher PA, Siman RG, Fehlings MG. 2000. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 74:1646-1655.
47. Sekhon LH, Fehlings MG. 2001. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26(Suppl 24):S2-S12. (Pubitemid 34019773)
48. Smith JA, Das A, Butler JT, Ray SK, Banik NL. 2009. Estrogen receptor agonist or estrogen inhibits lipopolysaccharide induced microglial death. J Neurochem 108(Suppl 1):137 (PTW104-107).
49. Sribnick EA, Wingrave JM, Matzelle DD, Ray SK, Banik NL. 2003. Estrogen as a neuroprotective agent in the treatment of spinal cord injury. Ann N Y Acad Sci 993:125-133; discussion 159-160.
50. Sribnick EA, Ray SK, Banik NL. 2004. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res 29:2007-2014.
51. Sribnick EA, Wingrave JM, Matzelle DD, Wilford GG, Ray SK, Banik NL. 2005. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res 82:283-293.
52. Sribnick EA, Matzelle DD, Ray SK, Banik NL. 2006a. Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res 84:1064-1075. (Pubitemid 44521051)
53. Sribnick EA, Ray SK, Banik NL. 2006b. Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism. Neuroscience 137:197-209.
54. Sribnick EA, Matzelle DD, Banik NL, Ray SK. 2007. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem Res 32:2210-2216.
55. 2+ influx through L-type voltage-gated Ca21 channels. Brain Res 1276:159-170.
56. Sribnick EA, Matzelle DD, Ray SK, Banik NL. 2009b. Estrogen as a prospective multi-active agent for the treatment of spinal cord injury. In: Banik NL, Ray SK, editors. Brain and spinal cord trauma,3rd ed. New York: Springer. p 581-598.
57. Sternberger LA, Sternberger NH. 1983. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc Natl Acad Sci U S A 80:6126-6130.
58. Sur P, Sribnick EA, Wingrave JM, Nowak MW, Ray SK, Banik NL. 2003. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 971:178-188. (Pubitemid 36423319)
59. Tyor WR, Avgeropoulos N, Ohlandt G, Hogan EL. 2002. Treatment of spinal cord impact injury in the rat with transforming growth factor-β. J Neurol Sci 200:33-41. (Pubitemid 34792739)
60. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, Maggi A. 2003. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 100:9614-9619. (Pubitemid 37033976)
61. Wen Y, Yang S, Liu R, Perez E, Yi KD, Koulen P, Simpkins JW. 2004. Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 1008:147-154. (Pubitemid 38624044)
62. Wingrave JM, Sribnick EA, Wilford GG, Matzelle DD, Mou JA, Ray SK, Hogan EL, Banik NL. 2004. Relatively low levels of calpain expression in juvenile rat correlate with less neuronal apoptosis after spinal cord injury. Exp Neurol 187:529-532. (Pubitemid 38610299)
63. Wu HY, Tomizawa K, Oda Y, Wei FY, Lu YF, Matsushita M, Li ST, Moriwaki A, Matsui H. 2004. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 279:4929-4940. (Pubitemid 38199089)
64. Xie LP, Fu WX, Jin C, Dong XY, Chen WF. 2002. Negative regulation of monocyte chemoattractant protein-1 gene expression by a mouse estrogen-enhanced transcript. Eur J Immunol 32:2837-2846. (Pubitemid 35238176)
65. Yune TY, Kim SJ, Lee SM, Lee YK, Oh YJ, Kim YC, Markelonis GJ, Oh TH. 2004. Systemic administration of 17β-estradiol reduces apoptotic cell death and improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 21:293-306.